# Understanding merger control remedies in China

**Authors:** Shengyan Hu, Jiong Gong

PMC · DOI: 10.1371/journal.pone.0336795 · PLOS One · 2025-11-21

## TL;DR

This paper evaluates the effectiveness of merger control remedies in China from 2008 to 2018 using a synthetic control method.

## Contribution

The study introduces a novel approach to assess merger remedies by comparing real cases with counterfactual scenarios.

## Key findings

- Remedies in merger cases are generally effective in maintaining competition.
- Structural remedies show more immediate and significant effects compared to behavioral remedies.

## Abstract

We identified 8 merger cases with remedies in China for a period from the time when the Anti-monopoly Law was enacted in 2008–2018, and about 150 other merger cases corresponding to these 8 cases in their respective industries but approved without remedies. We then use the latter data to construct a counterfactual for the former to compare the factually observed level of competition after the merger decision with that derived from the counterfactual, based on a method called the synthetic control method (SCM). The exercise allows us to assess the remedies’ effectiveness. We find that overall the remedies are effective, but the structural remedies’ effect tends to be more abrupt and pronounced than behavioral remedies.

## Full-text entities

- **Diseases:** AML (MESH:D006679), PCM (MESH:D010437)
- **Chemicals:** NXP (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12637943/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12637943/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12637943/full.md

---
Source: https://tomesphere.com/paper/PMC12637943